Who has invested in Adlai Nortye?

SDIC, WuXi Biologics, Tigermed are named among the investors backing Adlai Nortye.

Adlai Nortye Funding: $403M Raised, Growth (2026)

Adlai Nortye funding overview

Adlai Nortye is based in Hangzhou, China. Adlai Nortye has raised $403M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in April 2026. The round record for Adlai Nortye runs through 2026; nothing later has been disclosed. Investors on record include SDIC, WuXi Biologics, Tigermed. 3 distinct backers are named across the disclosed rounds.

Adlai Nortye at a glance

Total raised: $403M
Latest round: Growth
Latest round date: April 2026
Headquarters: Hangzhou, China
Notable investors: SDIC, WuXi Biologics, Tigermed

Frequently asked about Adlai Nortye funding

How much has Adlai Nortye raised?: Adlai Nortye has raised $403M in total disclosed funding across the rounds on record.
Who has invested in Adlai Nortye?: SDIC, WuXi Biologics, Tigermed are named among the investors backing Adlai Nortye.
What was the latest Adlai Nortye funding round?: The most recent disclosed round is a Growth, announced in April 2026.
Where is Adlai Nortye based?: Adlai Nortye is based in Hangzhou, China.
When did Adlai Nortye last raise?: The last disclosed Adlai Nortye round closed in April 2026 at Growth.

Round data for Adlai Nortye is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Hangzhou and backer lists below.

Adlai Nortye Funding: $403M Raised, Growth (2026)

Adlai Nortye funding overview

Adlai Nortye at a glance

Frequently asked about Adlai Nortye funding

Companies related to Adlai Nortye (26)

Browse related funding lists (4)